Royal Bank of Canada
SOPH icon

Royal Bank of Canada’s SOPHiA GENETICS SOPH Stock Holding History

Royal Bank of Canada’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96K Buy
19,381
+18,781
+3,130% +$91.4K ﹤0.01% 5149
2025
Q4 		$3K Hold
600
– – ﹤0.01% 6850
2025
Q3 		$3K Hold
600
– – ﹤0.01% 6822
2025
Q2 		$2K Hold
600
– – ﹤0.01% 6815
2025
Q1 		$2K Hold
600
– – ﹤0.01% 6592
2024
Q4 		$2K Hold
600
– – ﹤0.01% 6728
2024
Q3 		$2K Sell
600
-15
-2% -$61 ﹤0.01% 6659
2024
Q2 		$3K Buy
615
+15
+3% +$73 ﹤0.01% 6674
2024
Q1 		$3K Hold
600
– – ﹤0.01% 6616
2023
Q4 		$3K Buy
+600
New +$2.24K ﹤0.01% 6751

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $369M AUM 45.79% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Royal Bank of Canada's SOPH Position: Q1 2026 in Review

Royal Bank of Canada increased its SOPHiA GENETICS (SOPH) stake by 3,130% in Q1 2026, buying an estimated $91.4K and bringing the position to 19,381 shares worth $96K. The position accounts for ﹤0.01% of the portfolio, ranked #5149.

Royal Bank of Canada first reported a position in SOPH in Q4 2023 and has held it in 10 quarters since. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

  • Royal Bank of Canada held 19,381 shares of SOPHiA GENETICS worth $96K as of Q1 2026.
  • Royal Bank of Canada bought 18,781 SOPHiA GENETICS shares in Q1 2026, an estimated $91.4K.
  • SOPHiA GENETICS made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5149 holding.
  • Royal Bank of Canada first reported a position in SOPHiA GENETICS in Q4 2023 and has held it in 10 quarters since.
  • 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.